Bryan Kay
FDA grants approval for IDE study on Advance Evero 18 everolimus-coated...
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero...
Not all carotid procedures are equal after patients suffer a postoperative...
Comparative analysis looks at stroke-related disability and mortality after three modes of carotid revascularization.
Strokes after transfemoral carotid artery stenting (TFCAS) were “the most disabling...
Aquedeon Medical receives FDA approval to expand clinical trial of Duett...
The Food and Drug Administration (FDA) has approved the expansion of Aquedeon Medical's investigational device exemption (IDE) clinical trial evaluating the Duett vascular graft system,...
In wake of President Trump’s chronic venous insufficiency diagnosis, SVS steps...
News that U.S. President Donald J. Trump has a vascular condition may have simultaneously revealed that a substantial seven-figure vascular surgery branding campaign was...
Vascular Specialist–August 2025
In this issue:
Artificial intelligence: Where it lands today and how it might impact the vascular future
In wake of President Trump’s chronic venous...
Regional vascular societies gear up for fall annual meetings
The glut of early fall regional vascular society annual meetings is just around the corner, with no fewer than five slated for the month...
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass...
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic...
Early bird pricing deadline for coding workshop falls tomorrow
The early bird pricing deadline for this year’s SVS Coding & Reimbursement Workshop is tomorrow.
With significant coding changes going into effect for vascular surgery...
Deadline extended for SVS Foundation grant focused on women’s health
The Society for Vascular Surgery (SVS) Foundation has extended the deadline for a Vascular Care for the Underserved (VC4U) project grant focused on women's...
Inari Medical, now part of Stryker, launches InThrill thrombectomy system
Inari Medical—now part of Stryker—has announced the launch of its next-generation InThrill thrombectomy system.
The company stated in a recent press release that this is...
SVS highlights landmark paper on functional popliteal artery entrapment syndrome
The Society for Vascular Surgery has highlighted findings from a comprehensive 20-year clinical study that demonstrate treatment of functional popliteal artery entrapment syndrome—particularly in...
Getinge’s iCast covered stent system approved as bridging stent in US
Getinge recently announced that it has received Food and Drug Administration (FDA) premarket approval (PMA) for the iCast covered stent system. The device is...
Medtronic enrols first patient in Onyx liquid embolic IDE clinical study
Medtronic today announced that the first patient has been enrolled in the Peripheral Onyx liquid embolic (PELE) clinical trial, which will evaluate the safety...
Vascular Specialist–July 2025
In this issue:
Vascular unity: ‘Let’s stop standing on the sidelines while others define what vascular care looks like’
Vascular surgery history: Putting...
Medtronic to distribute FMD’s peripheral guidewires for transradial access in US
Medtronic today announced it has entered into an exclusive U.S. distribution agreement with Japan-based Future Medical Design Co (FMD) to sell specialty and workhorse...
Cook announces US launch of Zenith iliac branch device
Cook Medical has announced that its Zenith iliac branch device (ZBIS) is now commercially available in the U.S. with Food and Drug Administration (FDA)...
Vascular surgery history: Putting specialty on the map in a broader...
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today formed the bedrock of the subject matter...
Humacyte announces Symvess ECAT approval from US Defense Logistics Agency
Humacyte announced today that Symvess has been awarded Electronic Catalog (ECAT) listing approval from the U.S. Defense Logistics Agency.
ECAT is an internet system...
Presenting a united front to address vascular surgery’s structural and financial...
Vascular surgeons must present a unified front in order to address structural and financial challenges facing the specialty, Society for Vascular Surgery (SVS) President-Elect...
RESCUE II results on Thrombolex’s Bashir endovascular catheter for PE published
Thrombolex recently announced the publication of RESCUE-II study results in JACC: Advances.
The RESCUE-II study was a single-centre, prospective study evaluating the safety and...
Cook Medical issues Class I recall for Beacon Tip angiographic catheters
Cook Medical has initiated a Class I recall of its Beacon Tip 5F angiographic catheter.
This follows reports of tip separation that could result...
StentIt launches first-in-human trial of bioresorbable stent to treat below-the-knee CLTI
StentIt has announced the successful implantation of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1 study, patients with chronic limb-threatening ischemia...
Vivasure Medical submits premarket approval to FDA for PerQseal Elite closure...
Vivasure Medical has announced the submission of a premarket approval application to the Food and Drug Administration (FDA) for its PerQseal Elite vascular closure...
Gore Tag thoracic branch endoprosthesis receives expanded FDA approval for endovascular...
Gore has announced that the Gore Tag thoracic branch endoprosthesis (TBE) is now approved by the Food and Drug Administration (FDA) for use in...
Penumbra’s STORM-PE randomized trial completes enrollment
Penumbra has announced the completion of enrollment in the STORM-PE clinical trial.
The pivotal, prospective, multicenter randomized controlled trial enrolled 100 patients to evaluate computer...
Aventus thrombectomy system gains FDA clearance for PE treatment
Inquis Medical has announced that its Aventus thrombectomy system has received 510(k) clearance from the US Food and Drug Administration (FDA) for an expanded...
The people and devices that put ‘the vascular in vascular’
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today will form the subject matter for this...
Vascular surgery maintains popularity, becomes ‘more competitive’ after switch to virtual...
A study aimed at assessing the impact of a pandemic-related switch to virtual recruitment from in-person interviews on the Match for vascular surgery residents...
International Chapter highlights pressing need to document PAD and CLTI prevalence...
There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in...
Acellular tissue engineered vessel outperforms AVF in high-risk hemodialysis patients
Results from the CLN-PRO-V007 randomized controlled trial of Humacyte’s acellular tissue engineered vessel (ATEV) are set to be shared today during VAM 2025 Plenary...
Transcatheter arterialization of the deep veins: Comparative analysis probes whether emerging...
“We're living in a new world order” when it comes to “no-option” chronic limb-threatening ischemia (CLTI) patients, says Anahita Dua, MD. In recent years,...
Drilling into controversies in field of asymptomatic severe carotid stenosis management
Some of the enduring controversies in the management of asymptomatic severe carotid stenosis will underpin an educational session set to take place today.
The session...
Vascular Specialist@VAM Conference Edition 2
In this issue:
One-year TAMBE data highlight low mortality, importance of renal branch assessment
Transcatheter arterialization of the deep veins: Comparative analysis probes...
No power, no problem! VAM 2025 pivots as early-morning power outage...
The vascular surgery world is used to pivoting on a dime. So it was as VAM 2025 was about to commence yesterday morning,...
Vascular Specialist@VAM Conference Edition 1
In this issue:
Crawford Forum: Empowering vascular surgeons
SVS Foundation Resident Research Award: Targeting highly complex process of calcification
VTE: Evolving landscape of interventions for...
Crawford Forum: Empowering vascular surgeons
This year’s E. Stanley Crawford Critical Issues Forum at the 2025 Vascular Annual Meeting (VAM) in New Orleans, from 11:15 a.m.–12:15 p.m., on the...
Vascular Specialist–June 2025
In this issue:
Helping OBL vascular surgeons fight the squeeze
‘Rise together’: Harris urges unity in Women’s Vascular Summit presidential address
Senior surgeons:...
Taking the lead: The vascular surgeon in the pediatric vascular surgical...
It’s a bit like realigning the narrative, ever so slightly. “I want us to feel, as a collective specialty, that pediatric vascular care falls...
Helping OBL vascular surgeons fight the squeeze
SVS Section on Ambulatory Vascular Care (SAVC) set to announce set of new initiatives designed to help office-based lab (OBL) vascular surgeons combat rising...
SVS names candidates for vacant officer positions
The Society for Vascular Surgery (SVS) announced the nominees for the vice president and secretary positions in April. Voting in this year's SVS elections...
Wound healing in space: Vascular surgeons produce wide-ranging review
How a group of vascular surgeons is working to plug gaps in knowledge and inspire colleagues to recognize the specialty’s essential role in future...
Survey suggests greater exposure to mini-incision carotid endarterectomy during training may...
While a recent survey found that a majority of those who responded had performed mini-incision carotid endarterectomy (CEA) at least once in their practice...
Equivalent outcomes seen among female, male patients in real-world analysis of...
The use of a paclitaxel-eluting stent to treat femoropopliteal occlusive disease led to equivalent outcomes in male and female patients in “a diverse and...
Vascular Specialist–May 2025
In this issue:
Wound healing in space: How a group of vascular surgeons is working to plug gaps in knowledge and inspire colleagues...
Imperative Care announces completion of enrollment in the SYMPHONY-PE study
Imperative Care has announced the completion of patient enrollment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and...
Three-year VenoValve first-in-human trial data published
Envveno Medical has announced that its manuscript titled, "Three-year outcomes of surgical implantation of a novel bioprosthetic valve for the treatment of deep venous...
VVT Medical welcomes Antonios Gasparis to medical advisory board
VVT Medical recently announced the appointment of Antonios Gasparis, MD, to its medical advisory board.
A press release notes that Gasparis brings over two decades...
Inquis Medical’s Aventus thrombectomy system found safe and effective for patients...
Inquis Medical recently announced results from its AVENTUS trial evaluating the safety and efficacy of the company’s Aventus thrombectomy system.
The results were presented by...
Visiting professorship recipient announced
The SVS Young Surgeons Section (YSS) has selected Nathan Liang, MD, of the University of Pittsburgh, to receive its 2025 visiting professorship.
Liang will...
New study validates BEST-CLI trial results, ‘suggesting generalizability’
A new propensity-matched analysis of more than 1,100 lower extremity revascularization procedures carried out in patients with chronic limb-threatening ischemia (CLTI)—which aimed to help...
‘The leader must own everything in his or her world, own...
“We can almost be considered a specialty of colonizers, acquiring borrowed techniques. Why, then, do we see ourselves as the keepers of vascular care?...
Debate verdict: Carotid endarterectomy maintains its golden hue
The established “gold-standard” approach to carotid revascularization remained enshrined as the go-to operation as far as a 2025 Charing Cross (CX) International Symposium audience...
R3 Vascular announces first patient treated in ELITE-BTK pivotal trial
R3 Vascular recently announced that the first patient in its ELITE-BTK pivotal trial has been treated by Brian DeRubertis, chief of vascular surgery at...
CX 2025: New VenaSeal data suggest cyanoacrylate closure be added to...
Twelve-month outcomes of the VenaSeal Spectrum venous leg ulcer (VLU) trial, assessing time to ulcer healing following treatment with the VenaSeal (Medtronic) closure system,...
CX 2025: EVAR founding fathers invoke revolutionary past to predict path...
The next spring forward in aortic stent grafting will be rooted in a greater understanding of the biomechanical forces acting upon devices alongside continued...
Vascular Specialist–April 2025
In this issue:
The question of Vascular Surgery Board independence: Federated or free-standing
From Brazil to Baylor: Gustavo Oderich lands at cardiovascular powerhouse
...
Early feasibility study for Velocity pAVF system now fully enrolled
Venova Medical has announced the completion of patient enrollment in the company's VENOS-2 early feasibility study of the Velocity percutaneous arteriovenous fistula (pAVF) system...
The question of Vascular Surgery Board independence: Federated or free-standing?
A survey recently went out to Society for Vascular Surgery (SVS) members asking them to contribute their voice to an opinion poll over whether...
Founding fathers of EVAR set to gather to mark 40 years...
The 40-year history of endovascular aneurysm repair (EVAR) of the aorta wends a circuitous route, from behind the Iron Curtain in Soviet Ukraine, to...
Terumo Neuro receives FDA approval for carotid stent system
Terumo Neuro has announced that its carotid stent system has received premarket approval (PMA) from the Food and Drug Administration (FDA).
This milestone marks the...
VenoValve: Analysis finds similar improvement among both primary and thrombotic deep...
A new subanalysis of the SAVVE (Surgical antireflux venous valve endoprosthesis) trial found that there was no difference in the level of improvement in...
Cagent Vascular initiates patient enrollment in Serranator vs. plain balloon angioplasty...
Cagent Vascular has announced its first patient enrolment in the Serranator versus plain balloon angioplasty optical coherence tomography (OCT) study.
This prospective, randomized (2:1 treatment...
SCVS 2025: Rowe becomes SCVS president
Vincent Rowe, MD, from the University of California, Los Angeles (UCLA), became the 2025–26 Society for Clinical Vascular Surgery (SCVS) president during the Society’s...
Novel phenotypic AAA classification may help better stratify aneurysm risk
Inspection of aortic lumen, wall and thrombus volume changes throughout the cardiac cycle enables novel classification of abdominal aortic aneurysms (AAAs) into four types...
Surmodics announces commercial release of Pounce XL thrombectomy system
Surmodics has announced the commercial release of the Pounce XL thrombectomy system for endovascular removal of acute or chronic clot from peripheral arteries.
Intended for removal...
Gore announces FDA approval and first commercial implant of large-diameter thoracic...
Gore recently announced the expansion of the Gore Tag conformable thoracic stent graft with Active Control system product line, following Food and Drug Administration...
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt...
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery...
SCVS 2025: Multicenter data show favorable role for FEVAR over chimney...
A multi-institutional analysis has demonstrated fenestrated endovascular aneurysm repair (FEVAR) could be a “safer and more durable option” than chimney EVAR (ChEVAR) in elective...
Vascular Specialist–March 2025
In this issue:
Multicenter data show favorable role for FEVAR over chimney grafts
SVS, medical organizations launch comprehensive Wound Care Curriculum
Guest editorial: Redefining...
Study details radiation exposure learning curve among vascular trainees
The importance of radiation safety training for vascular surgery trainees was highlighted by a recent study that detailed a learning curve effect between first-...
Novel thrombectomy system for VTE used successfully in first tranche of...
SonoVascular has announced the successful completion of an initial set of eight deep vein thrombosis (DVT) cases using its SonoThrombectomy system as part of...
‘How to thrive, not just survive, as a vascular surgeon’
Outgoing Vascular & Endovascular Surgery Society (VESS) President Misty Humphries, MD, used her presidential address to outline how trainees and young vascular surgeons can...
Vascular surgery trainee autonomy driven by well-being, study finds
A new cross-sectional analysis as part of the SECOND trial found that most vascular surgery trainees are satisfied with their operative and clinical autonomy...
Inari Medical, now part of Stryker, launches Artix thrombectomy system
Inari Medical, now part of Stryker, recently announced the launch of its Artix thrombectomy system. Purpose-built for the needs of the peripheral arterial system,...
Philips issues Class I recall for Tack endovascular system
Philips has recently announced that it will no longer sell its Tack endovascular system in the U.S. following a Class I recall issued by...
Shockwave Medical announces US launch of intravascular lithotripsy catheter
Today, Shockwave Medical announced the U.S. launch of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a platform designed to modify calcium and cross...
‘Battlefield first aid’: A peer-to-peer prescription for dealing with adverse surgical...
“Battlefield first aid” after a colleague has a bad case as the cornerstone of peer-to-peer support in vascular surgery was the feature of the...
AVF: From good to great
Ruth Bush, MD, used her 2025 American Venous Forum (AVF) presidential address to highlight the organization’s elevation and path to “level 5 leadership.”
Level 5...
Open surgery, endovascular intervention and robotics: The coming ‘third revolution’ in...
The 2025 Southern Association for Vascular Surgery (SAVS) presidential address featured the hashtag phrase #OnlyUs, an allusion to the specialty’s “unique” differentiator.
SAVS 2024–25 President...
AVF 2025: A call for ‘second-generation steps’ in venous stenting
The need for a revolutionary second generation of venous stents are among the gaps and unmet needs currently at play in deep venous surgery,...
Ketamine reduces postoperative opiate use and pain scores as part of...
The introduction of ketamine into a spinal cord ischemia (SCI) protection protocol used during thoracoabdominal aortic aneurysm (TAAA) repairs led to significant reductions in...
FFRCT diagnosis of coronary ischemia with ischemia-targeted coronary revascularization more than...
Preoperative diagnosis of lesion-specific ischemia using coronary computed tomography (CT)-derived fractional flow reserve (FFRCT) and ischemia-targeted coronary revascularization after carotid endarterectomy (CEA) can reduce...
New analysis details learning curve effect behind ‘significant improvement’ in performance...
A multisite hospital system analysis of the safety and procedural learning curve behind the performance of percutaneous mechanical thrombectomy for pulmonary embolism (PE) shows...
Vascular Specialist–January/February 2025
In this issue:
US ARC uncovers ‘dramatic’ decrease in use of prophylactic spinal drains at same time as spinal cord ischemia steeply declines
Interview:...
Shape Memory Medical announces first European enrolment in AAA-SHAPE pivotal trial
Shape Memory Medical today announced the first European enrollment in the AAA-SHAPE pivotal trial, the company’s prospective, multicenter, randomized, open-label trial to determine the...
Stryker completes acquisition of Inari Medical
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established...
Reflections from VESS: Internal mentoring, external inspiration and really good skiing
Just over a week ago, I was racing my medical school vascular surgery attending, Dr. Adam Doyle, down a Breckenridge run memorably named “The...
Study demonstrates textbook outcomes occur less than a quarter of the...
Textbook outcomes remain “very rare” after revascularization for chronic limb-threatening ischemia (CLTI), with the main driver being an enduring inability to attain complete wound...
BEST-CLI trial spline model analysis breaks new ground in assessing the...
A new analysis of the BEST-CLI trial has produced the first evidence-based glomerular filtration rate (eGFR) value—30 mL/min/1.73 m2—as the cutoff below which patients...
Deep vein arterialization: Much remains to be learned but use poised...
These remain early days for transcatheter arterialization of the deep veins (TADV) in the setting of patients with severe chronic limb-threatening ischemia (CLTI), says...
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism...
Penumbra launches Element vascular access system for VTE
Penumbra recently announced the launch of its Element vascular access system. This is the first laser-cut hypotube sheath designed for venous thromboembolism (VTE), the...
US ARC uncovers ‘dramatic’ decrease in use of prophylactic spinal drains...
Despite a “dramatic” decrease in the use of prophylactic cerebrospinal fluid drains (CSFDs) for the prevention of spinal cord ischemia (SCI) in patients undergoing...
Tracci assumes presidency of Southern Vascular
Margaret (Megan) Tracci, MD, has become the first-ever woman president of the Southern Association for Vascular Surgery (SAVS). The University of Virginia professor of...
FDA announces plans to address medical device shortage risks
The Food and Drug Administration (FDA) has issued a statement outlining measures to enhance protections against medical device shortages.
According to Michelle Tarver, director...
One-year SAVVE trial results are ‘most encouraging data ever produced for...
The one-year data from the SAVVE trial represent the “most encouraging clinical data that have ever been produced for a bioprosthetic deep vein valve”...
Study reports lack of evidence to support theory that hospital integration...
A systematic review of U.S. literature focused on analyzing the effects of mergers and acquisitions on healthcare suggests that there is a lack of...
Novel sirolimus-eluting scaffold system demonstrates ‘potential to address Achilles’ heel’ of...
Ongoing studies of the Efemoral vascular scaffold system (EVSS)—previously described as a potential new paradigm in the treatment of long occlusive lesions—show that the...
How physician assistants help vascular surgery teams provide ‘continuity of care’
The key role played by physician assistants (PAs) as part of vascular surgery teams in the U.S. came into focus during the Vascular Societies’...
Vascular trainees better prepared for open aortic practice than commonly reported,...
Current graduates from both vascular surgery residency and fellowship programs are well prepared for surgical practice in aortic disease whether they are performing open...
The endovascular revolution and open aortic training: ‘It’s not necessarily a...
Jean Panneton, MD, considers himself what he terms a “blue-collar” vascular surgeon as much as one engaged in academic practice and the necessity of...
Vascular Specialist–December 2024
In this issue:
Positive one-year data for new venous valve portends promising future in chronic venous insufficiency treatment
Vascular trainees better prepared for open...
Merit Medical announces FDA approval of the Wrapsody cell-impermeable endoprosthesis
Merit Medical Systems announced today that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this...
Positive one-year data for new venous valve portends promising future in...
SAVVE trial principal investigators discuss results showing 98.4% VenoValve device patency, 85% clinically meaningful benefit and an 80% rate of ulcer size reduction at...
Novel bioabsorbable perivascular wrap aims to reduce AVF failure
Ellen Dillavou, MD, division chief of vascular surgery at WakeMed Heart Center in Raleigh, North Carolina, primary investigator (PI) for the VenoStent trial, presented...
When RCTs are essential for novel vascular access device regulation
As part of a 2024 VEITHsymposium (New York City; Nov. 19–23) debate, Robert E Lee, MD, a medical officer recently retired from the Food...
Artivion granted FDA humanitarian device exemption for the AMDS hybrid prosthesis
Artivion recently announced that the Food and Drug Administration (FDA) has granted a humanitarian device exemption (HDE) for use of the AMDS hybrid prosthesis...
VASC.AI: Canadian vascular surgery researchers develop vascular-specific bot aimed at aiding...
The advent of large language models such as ChatGPT (Open AI) has left little of the world untouched—and a quintet of University of Toronto...
Service: Giving back
Pioneering American Venous Forum (AVF) and Eastern Vascular Society (EVS) efforts aimed at breaking down barriers to care and educating patients in economically challenged...
Novel measure suggests 20% of elective carotid revascularizations fail to achieve...
One in five patients failed to achieve a textbook outcome after undergoing carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR) or transfemoral carotid artery stenting...
Bentley announces first-in-human implantation of BeFlared bridging stent
Bentley has announced the successful first-in-human implantation of its recently CE-certified BeFlared stent graft system, which the company states is the world’s first dedicated...
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
BEST-CLI: Trial results endure in analysis of patients who presented with...
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of...
Rates of MAE and reintervention following F/BEVAR remain ‘stable,’ Aortic Research...
Latest study out of consortium details trends and outcomes after F/BEVAR procedures carried out over an eight-year period under consortium of 10 physician-sponsored IDEs.
Despite...
Vascular Specialist–November 2024
In this issue:
Service: Giving back—The Eastern Vascular Society (EVS) and American Venous Forum (AVF) pioneer vascular days of service in the community
...
PMA application submitted for VenoValve device
enVVeno Medical today announced it has submitted an application with the U.S. Food and Drug Administration (FDA) seeking approval to market the VenoValve—a surgical...
Endoscopic vein harvest under the microscope
Conflicting results open fresh debate around effect of vein harvesting technique on long-term patency of lower extremity bypass grafts.
Two separate analyses that looked at...
The Japanese concept of ikigai and how mentorship might help specialty...
The Japanese concept of ikigai, or an individual’s reason for being, underpinned the message behind a fresh call for mentorship in vascular surgery and...
NESVS 2024: Simons becomes first woman president of New England Society...
Jessica P. Simons, MD, has become the 2024–25 president of the New England Society for Vascular Surgery (NESVS). She is the first woman to...
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH...
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive...
A calling seeded in childhood: Uniting vascular surgery for the betterment...
Many attending the 2024 Vascular Annual Meeting (VAM; June 19–22) might have been unaware of the early life of 2023–24 Society for Vascular Surgery...
‘We are in this together’: SVS president set to issue call...
SVS President Joseph Mills, MD, is set to issue a rallying call steeped in classical history and decades of collected vascular surgery wisdom in...
CX united: Vascular world set to converge with challenging cases
The World Federation of Vascular Societies (WFVS) is bringing the vascular world together at CX 2024 to chew over both challenging cases and leadership...
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those...
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the...
FORS-powered LumiGuide 3D imaging technology is rolled out at specialized centers...
Andres Schanzer, MD, has hailed it "one of the most exciting changes" seen in imaging during the course of his career. Philips’ LumiGuide "human...
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address.
From 11:00 a.m.–12:15...